Investors Face November Deadline in Hims & Hers Securities Lawsuit

The legal complaint alleges that the telehealth company misled shareholders by failing to disclose critical operational practices during the specified period. Central to the allegations is the claim that Hims & Hers shared sensitive consumer health data with third-party advertising platforms without proper transparency. Furthermore, the suit suggests the company aggressively charged for prescriptions immediately after intake forms were submitted, despite marketing claims that patients would first undergo a consultation to determine appropriate treatments.

These actions reportedly exposed the company to significant regulatory risk and potential financial penalties, undermining the accuracy of previous public statements regarding the firm's business health. Investors seeking to participate in the litigation must formally move the court by the November deadline. While Glancy Prongay Wolke & Rotter LLP is actively soliciting potential plaintiffs, affected shareholders retain the right to select their own legal counsel or remain absent class members until a class is officially certified.